Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 2
2001 1
2004 2
2005 5
2006 3
2007 8
2008 5
2009 6
2010 7
2011 7
2012 7
2013 9
2014 7
2015 7
2016 2
2017 5
2018 1
2019 5
2020 5
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Pioglitazone hydrochloride/glimepiride.
Blake EW. Blake EW. Drugs Today (Barc). 2007 Jul;43(7):487-97. doi: 10.1358/dot.2007.43.7.1073850. Drugs Today (Barc). 2007. PMID: 17728849 Review.
The combination of pioglitazone hydrochloride, a thiazolidinedione, and glimepiride, a sulfonylurea, has been approved in many countries worldwide as an oral agent for the management of type 2 diabetes. ...Pioglitazone and glimepiride als …
The combination of pioglitazone hydrochloride, a thiazolidinedione, and glimepiride, a sulfonylurea, has been ap …
Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis.
Zhang YS, Zheng YD, Yuan Y, Chen SC, Xie BC. Zhang YS, et al. Front Endocrinol (Lausanne). 2021 Oct 14;12:735824. doi: 10.3389/fendo.2021.735824. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34721294 Free PMC article.
Risk ratio (RR) with its 95% confidence interval (CI) was calculated by combining data for the fracture effects of anti-diabetic drugs, including sodium-glucose co-transporter 2 (SGLT2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) …
Risk ratio (RR) with its 95% confidence interval (CI) was calculated by combining data for the fracture effects of anti-diabetic drug …
[Fixed-dose combination].
Nagai Y. Nagai Y. Nihon Rinsho. 2015 Mar;73(3):465-9. Nihon Rinsho. 2015. PMID: 25812374 Japanese.
Fixed-dose combination therapy(FDC) offers a method of simplifying complex regimens. ...In addition, FDC can enhance adherence and improved adherence may result in improved glycemic control. Four FDC agents are available in Japan: pioglitazone-glimepiride, …
Fixed-dose combination therapy(FDC) offers a method of simplifying complex regimens. ...In addition, FDC can enhance adherence and im …
Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study.
Ragazzi E, Burlina S, Cosma C, Chilelli NC, Lapolla A, Sartore G. Ragazzi E, et al. Front Endocrinol (Lausanne). 2023 Aug 11;14:1163554. doi: 10.3389/fendo.2023.1163554. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635976 Free PMC article. Clinical Trial.
METHODS: Seventy-three patients with type 2 diabetes mellitus were randomly assigned to a drug therapy with pioglitazone or glimepiride, combined to metformin. ...Pioglitazone was more effective than glimepiride in reducing AGE/s-RAGE rat …
METHODS: Seventy-three patients with type 2 diabetes mellitus were randomly assigned to a drug therapy with pioglitazone or …
Teneligliptin: a review in type 2 diabetes.
Scott LJ. Scott LJ. Clin Drug Investig. 2015 Nov;35(11):765-72. doi: 10.1007/s40261-015-0348-9. Clin Drug Investig. 2015. PMID: 26475720 Review.
In 12- or 16-week, placebo-controlled phase 2 and 3 trials, oral teneligliptin 20 or 40 mg once daily, as monotherapy or in combination with metformin, glimepiride or pioglitazone improved glycaemic control, including in patients with end-stage renal disease, …
In 12- or 16-week, placebo-controlled phase 2 and 3 trials, oral teneligliptin 20 or 40 mg once daily, as monotherapy or in combination …
Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.
Vaughan EM, Rueda JJ, Samson SL, Hyman DJ. Vaughan EM, et al. Curr Diabetes Rev. 2020;16(8):851-858. doi: 10.2174/1573399816666200206112318. Curr Diabetes Rev. 2020. PMID: 32026779 Free PMC article. Review.
Cardiovascular event rates did not increase with lower glyburide doses (p<0.05). Glimepiride and pioglitazone have been successfully used in renal impairment. CONCLUSION: Metformin, glimepiride, and pioglitazone are safe and efficacious OHMs. Prescr …
Cardiovascular event rates did not increase with lower glyburide doses (p<0.05). Glimepiride and pioglitazone have been suc …
Drug evaluation: vildagliptin-metformin single-tablet combination.
Tahrani AA, Piya MK, Barnett AH. Tahrani AA, et al. Adv Ther. 2009 Feb;26(2):138-54. doi: 10.1007/s12325-009-0010-0. Epub 2009 Mar 19. Adv Ther. 2009. PMID: 19288260 Review.
The single-tablet combination of vildagliptin and metformin addresses key defects of type 2 diabetes for improved glycemic control. ...In active-controlled trials, the vildagliptin-metformin combination has been shown to produce equivalent reductions in hemoglobin A …
The single-tablet combination of vildagliptin and metformin addresses key defects of type 2 diabetes for improved glycemic control. . …
Pioglitazone plus glimepiride: a promising alternative in metabolic control.
Derosa G. Derosa G. Int J Clin Pract Suppl. 2007 Jun;(153):28-36. doi: 10.1111/j.1742-1241.2007.01362.x. Int J Clin Pract Suppl. 2007. PMID: 17594391 Review.
A fixed-dose combination of pioglitazone and glimepiride in a single tablet is now available in the US (Duetact(TM)). ...Furthermore, pioglitazone and glimepiride affect a number of pleiotropic markers. ...
A fixed-dose combination of pioglitazone and glimepiride in a single tablet is now available in the US (Duetact(TM)). . …
A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.
Dorkhan M, Frid A. Dorkhan M, et al. Vasc Health Risk Manag. 2007;3(5):721-31. Vasc Health Risk Manag. 2007. PMID: 18078023 Free PMC article. Review.
These defects have been treated in clinical praxis by use of oral insulin secretagogues (sulfonylureas/ glinides) or insulin, biguanides, and thiazolidinediones (TZDs) respectively. Pioglitazone HCL is an insulin sensitizer in the TZD family and glimepiride is an in …
These defects have been treated in clinical praxis by use of oral insulin secretagogues (sulfonylureas/ glinides) or insulin, biguanides, an …
Simultaneous spectrophotometric determination of glimepiride and pioglitazone in binary mixture and combined dosage form using chemometric-assisted techniques.
El-Zaher AA, Elkady EF, Elwy HM, Saleh MAEM. El-Zaher AA, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jul 5;182:175-182. doi: 10.1016/j.saa.2017.03.028. Epub 2017 Mar 14. Spectrochim Acta A Mol Biomol Spectrosc. 2017. PMID: 28437738
The proposed chemometric techniques were successfully applied to a pharmaceutical preparation containing a combination of pioglitazone and glimepiride in the ratio of 30: 4, showing good recovery values. ...It was carried out by an intrinsic comparison betwee …
The proposed chemometric techniques were successfully applied to a pharmaceutical preparation containing a combination of pioglita …
96 results